Gene Query: SHCBP1

Dataset Description Geneva Score
Genome-wide transcriptional response to random aneuploidy in human cells 96.69
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 74.29
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 74.29
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 69.54
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 68.8
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 62.38
Effect of CHKA knockdown on C4-2 cell transcriptome 59.9
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 57.62
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 53.76
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 51.15
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 48.42
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 46.99
Expression level comparison under dividing and quiescent states in human primary fibroblasts 43.55
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 42.88
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 42.33
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 39.53
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 39.53
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 38.28
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 38.26
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 37.63
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 35.86
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 35.62
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 34.33
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 33.72
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 33.46
Transcriptional profiles of normal human mature B cells 33.12
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 33.1
Transcriptome analysis of U87 cells upon LINC00152 knockdown 32.83
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 32.82
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 32.56
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 32.56
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 31.67
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 30.14
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 28.83
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 28.04
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 27.77
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 26.81
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 26.75
A transcriptome-wide divergence in protein translation scales with LIN28B expression 26.74
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 26.47
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 26.08
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 25.72
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 25.67
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 25.67
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 25.39
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 25.35
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 25.33
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 25.12
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 24.88
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 24.73
RNA-seq analysis to identify the genes regulated by p53-SET interplay 23.86
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 23.55
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 23.55
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 22.97
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 22.87
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 22.79
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 22.64
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 22.47
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 22.06
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 22.06
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 22.06
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 21.68
Effect of mitochondria deficiency on senescence-associated gene expression 21.53
A549 cells and MSR-A549 cells 21.31
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 21.31
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 21.31
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 21.19
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 21.15
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 20.85
miR941 overexpression experiment 20.58
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 20.37
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 20.18
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 19.86
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 19.44
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 19.43
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 19.43
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 19.32
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 19.31
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 18.83
Chromatin landscape of human visceral and subcutaneous adipocytes 18.5
Illumina Total RNA-seq in HeLa 18.43
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 18.42
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 18.32
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 18.32
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 18.32
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 18.28
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 18.27
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 18.25
Identification of global regulators of T-helper cell lineage specification 18.25
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 18.14
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 17.94
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 17.85
Global gene expression profile of dasatinib-resistant RCH-ACV cells 17.7
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 17.67
Transcription control by the ENL YEATS domain in acute leukemia 17.67
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 17.43
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 17.27
MYCi361 regulates MYC target genes 16.84
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 16.84
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 16.69
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 16.6
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 16.49
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 16.46
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 16.46
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 16.46
RNA-seq of resting and activated CD4+ T cells +-JQ1 16.38
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 16.35
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 16.29
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 16.28
RNA-seq of young and quiescent MRC-5 human fibroblasts 16.18
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 16.13
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 15.94
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 15.92
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 15.85
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 15.85
The regulartory role of ZCCHC24 in splicing machinery 15.77
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 15.71
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 15.48
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 15.46
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 15.35
Identification of differentially expressed genes between senescence and senescence bypass cells 15.18
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 15.14
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 15.02
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 15.02
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 14.96
Integrin signaling regulates YAP/TAZ to control skin homeostasis 14.82
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 14.52
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 14.52
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 14.46
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 14.46
Generation of trichogenic adipose-derived stem cells by expression of three factors 14.26
Differential gene expression in Jagged1 treated human dental pulp cells. 14.19
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 14.17
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 14.11
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 14.11
Disruption of the exocyst induces podocyte loss and dysfunction 14.03
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 13.97
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 13.94
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 13.94
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 13.86
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 13.59
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 13.53
The Genetic Landscape of Diamond-Blackfan Anemia 13.5
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 13.47
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 13.3
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 13.3
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 13.22
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 13.19
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 13.16
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 13.16
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 13.15
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 13.06
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 13.02
Differential analysis of gene regulation at transcript resolution by RNA-Seq 13.02
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 13.01
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 12.95
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 12.95
Effect of FGF13 depletion on the H460 cell line 12.92
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 12.89
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 12.89
Widespread intronic polyadenylation diversifies immune cell transcriptomes 12.76
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 12.75
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 12.72
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 12.72
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 12.68
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 12.56
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 12.56
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 12.53
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 12.47
A Unique Epigenomic Landscape Defines Human Erythropoiesis 12.42
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 12.42
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 12.4
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 12.4
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 12.4
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 12.33
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 12.28
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 12.21
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 12.19
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 12.16
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 12.14
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 12.11
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 12.09
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 12.04
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 12.0
Be1 and Be2 B cells are transcriptionally distinct 11.98
Transcriptome of U251 cells overexpression complement component 7 11.94
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 11.77
Genome wide miR-191 target profile determined by RIP and gene expression profiling 11.66
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 11.66
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 11.58
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 11.54
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 11.54
Effect of Influenza virus infection on lncRNA expression in A549 cells 11.52
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 11.45
Paxillin regulates genomic networks in prostate cancer [LNCaP] 11.44
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 11.31
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 11.3
Effect of PRDM11 depletion in U2932 cells 11.28
FBXW7 modulates stress response by post-translational modification of HSF1 11.26
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 11.26
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 11.24
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 11.23
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 11.19
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 11.18
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 11.15
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 11.15
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 11.13
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 11.13
Expression profiling of etoposide-induced senescent cells 11.01
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 10.97
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 10.94
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 10.89
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 10.88
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 10.8
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 10.72
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 10.68
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 10.67
Identification of Sin3B regulated genes during quiescence 10.66
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 10.65
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 10.65
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 10.65
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 10.61
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 10.55
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 10.55
A transcriptome dataset revealing the molecular features of breast cancer stem cells 10.52
RNA-seq of shEZH2 cells 10.48
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 10.46
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 10.31
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 10.31
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 10.3
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 10.15
Gene expression analysis of the impact of TDP-43 knockout in human cells. 10.14
RNA-seq analysis of uveal melanoma cells treated with FR900359 10.1
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 9.99
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 9.9
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 9.88
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 9.88
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.79
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 9.79
Transcriptome analysis of BAP1 knockout and restoration 9.77
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 9.77
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 9.74
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 9.68
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 9.66
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 9.65
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  9.62
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 9.56
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 9.53
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 9.49
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 9.48
TOP2B disturbed the quality of human oocytes with advanced maternal age 9.46
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 9.45
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 9.45
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 9.4
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 9.38
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 9.38
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 9.38
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 9.38
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 9.27
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 9.26
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 9.26
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 9.24
Gene expression profiling of human and murine in vitro muscle differentiation 9.22
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 9.21
6mer seed toxicity in tumour suppressive microRNAs 9.18
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 9.14
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 9.14
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 9.1
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 9.07
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.05
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 9.03
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 8.99
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 8.9
IRF2 is a master regulator of human keratinocyte stem cell fate 8.9
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 8.89
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 8.88
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 8.8
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 8.78
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.76
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 8.75
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 8.72
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 8.71
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 8.7
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 8.67
Identification of HOXB13 target genes responsive to BET inhibitors 8.67
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 8.65
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 8.62
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 8.61
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 8.56
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 8.56
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 8.56
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 8.56
Analysis of transcriptional regulation by Myt1 and Myt1l 8.54
RNA seq comparison between scrambled and shGRP78 cells 8.47
Genome-wide analysis of Dengue virus 2 infected cells 8.43
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 8.41
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 8.35
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 8.27
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 8.15
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 8.15
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 8.13
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 8.1
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 8.08
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 8.06
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 7.97
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 7.95
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 7.95
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 7.9
An acquired vulnerability of drug resistant melanoma with therapeutic potential 7.87
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 7.87
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 7.84
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 7.81
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 7.79
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 7.76
Gene expression profile in breast cancer cell lines using RNA sequencing 7.71
Paxillin regulates genomic networks in prostate cancer [PC3] 7.69
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 7.69
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.65
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 7.58
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 7.55
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 7.54
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 7.42
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 7.32
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 7.21
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 7.16
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 7.12
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 7.12
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.11
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 7.04
Zika virus infection reprograms global transcription of host cells to allow sustained infection 7.02
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 6.97
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 6.95
BACH2 in human plasma cell fate decision 6.89
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.88
Ro60-knockout cells 6.84
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 6.82
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 6.82
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.73
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.73
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 6.68
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 6.63
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 6.53
Small-molecule targeting of brachyury transcription factor addiction in chordoma 6.5
FOXP2's impact on the primate transcriptome 6.48
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 6.45
Downregulation of LATS kinases alters p53 to promote cell migration 6.42
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 6.41
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 6.41
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 6.39
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 6.39
A code of mono-phosphorylation modulates the function of RB. 6.36
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 6.3
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 6.28
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 6.26
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.14
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 6.02
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 6.02
Human Treg NaCl stimulation 6.02
Identification of global XBP1s target gene expression in human prostate cancer cells 5.97
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 5.71
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 5.68
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 5.64
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 5.64
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 5.58
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 5.58
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 5.49
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 5.46
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 5.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 5.35
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 5.35
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 5.32
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 5.32
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 5.31
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 5.25
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 5.2
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 5.19
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 5.19
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 4.98
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.94
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 4.92
Bone marrow derived human B cells [normal proB] 4.78
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 4.75
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 4.74
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.65
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 4.6
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 4.57
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.54
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.47
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.41
Effect of from Human Umbilical Vein Endothelial Cells 4.25
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 4.12
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 4.11
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 4.11
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.09
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 4.04
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 3.99
MCF-7 as a model for functional analysis of breast cancer risk variants 3.92
Transcriptomic analysis of LSD1 3.86
Proliferation-correlated expression 3.85
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 3.71
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 3.67
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 3.67
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 3.66
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 3.61
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 3.61
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 3.54
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  3.42
IMP3 regulated gene expression in breast cancer cells 3.39
6mer seed toxicity in viral microRNAs 3.35
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 3.23
Expression profiling of converted and control dermal BJ fibroblasts 3.23
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 3.21
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 3.18
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.14
The cohesin release factor WAPL restricts chromatin loop extension. 3.14
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 3.07
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.02
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 2.95
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 2.94
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 2.92
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 2.89
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.84
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 2.83
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.82
RNA-seq analysis of differentiating human erythroblasts 2.8
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 2.79
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.78
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.76
Transcriptome-wide modulation of splicing by the exon junction complex 2.57
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.49
Targeting MTHFD2 in Acute Myeloid Leukemia 2.47
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 2.45
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.41
RNA-seq analysis upon ARID1B overexpression 2.37
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 2.37
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 2.35
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.35
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 2.29
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.19
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.19
Human Treg IL-12 stimulation 2.15
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.13
Characterization of parental and rociletinib-resistant derived H1975 cell lines 2.13
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.03
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.99
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.96
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 1.9
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.9
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.86
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.76
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.76
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 1.74
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.73
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.73
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 1.67
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 1.59
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.58
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.58
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.58
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.58
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.5
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 1.44
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 1.44
4sU-seq of HFF exposed to salt and heat stress 1.42
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 1.41
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 1.41
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.36
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.36
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.3
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.28
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.28
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.28
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.27
Gene expression profile of CRC-derived HILEC 1.26
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.21
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.09
N6-methyladenine DNA Modification in Glioblastoma 1.09
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.93
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.93
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 0.85
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.85
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.67
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 0.67
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 0.67
SOX11 knockdown in B-ALL cell lines 0.66
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.63
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.61
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.6
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 0.57
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.55
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.49
Clinker: visualizing fusion genes detected in RNA-seq data 0.44
EGR1-controlled transcriptome of T HESCs 0.42
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.37
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.35
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 0.31
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 0.29
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.26
The cytokine environment influence on human skin-derived T cells 0.25
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.17


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation